ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. CanadaBis Capital's annualized return on invested capital (ROIC %) for the quarter that ended in Oct. 2025 was 3.26%.
As of today (2026-06-30), CanadaBis Capital's WACC % is 10.92%. CanadaBis Capital's ROIC % is 1.05% (calculated using TTM income statement data).
CanadaBis Capital earns returns that do not match up to its cost of capital. It will destroy value as it grows.
CanadaBis Capital (TSXV:CANB) ROIC % Explanation
ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.
There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.
Why is ROIC % important?
Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.
As of today, CanadaBis Capital's WACC % is 10.92%. CanadaBis Capital's ROIC % is 1.05% (calculated using TTM income statement data).
CanadaBis Capital earns returns that do not match up to its cost of capital. It will destroy value as it grows.
Be Aware
Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
CanadaBis Capital ROIC % Related Terms
CanadaBis Capital ROIC % Historical Data
* Premium members only.
The historical data trend for CanadaBis Capital's ROIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CanadaBis Capital ROIC % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's ROIC % distribution charts can be found below:
* The bar in red indicates where CanadaBis Capital's ROIC % falls into.
Note:
The Operating Income data used here is four times the quarterly (Oct. 2025) data.
The tax rate is limited to between 0% and 100%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CanadaBis Capital (TSXV:CANB) has a ROIC % of 3.26% as of Oct. 2025. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on CanadaBis Capital and its competitors.
Is CanadaBis Capital's ROIC % too high?
CanadaBis Capital's current ROIC % is 3.26%. The Drug Manufacturers industry median ROIC % is 4.46. CanadaBis Capital's value of 3.26% is 26.9% below this industry median.
How does CanadaBis Capital's ROIC % compare to NPHC and BSPK?
CanadaBis Capital's ROIC % of 3.26% can be compared against companies in the Drug Manufacturers industry. The industry median ROIC % is 4.46. CanadaBis Capital's value of 3.26% is 26.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROIC % for a Drug Manufacturers company?
The median ROIC % among Drug Manufacturers companies is 4.46, based on 982 companies in the industry. Companies in the top quartile (top 25%) have a ROIC % significantly above this median, while those in the bottom quartile fall well below. However, ROIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CanadaBis Capital's current ROIC % of 3.26% is 26.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROIC % mean?
A high ROIC % can signal that a stock is expensive relative to its fundamentals. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on CanadaBis Capital and its competitors. For the Drug Manufacturers industry, the median ROIC % is 4.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CanadaBis Capital's current ROIC % is 3.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CanadaBis Capital stock overvalued right now?
CanadaBis Capital (TSXV:CANB) has a current ROIC % of 3.26%. The stock's GF Value™ is C$0.07, compared to a current price of C$0.02 — trading 78.6% below its estimated fair value. The current ROIC % is 3.26% and 26.9% below the Drug Manufacturers industry median of 4.46. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROIC % calculated?
ROIC % is calculated from a company's financial statements. For CanadaBis Capital (TSXV:CANB), the current ROIC % is 3.26% as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CanadaBis Capital Inc is a vertically integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extract. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premises owned and operated by the Company. Extract segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extract Segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:CANB has been successfully added to your 